Agenda
#Blockchain4ClinicalTrials
IEEE Blockchain for Clinical Trials Forum – Europe
13-15 November – Clinical Innovation Zone, Glasgow Scotland
https://blockchain.ieee.org/standards/clinicaltrialseurope18
DAY 1: Wearables & Medical IoT Interoperability & Intelligence (WAMIII) Track
Addressing challenges, opportunities and needs for validating data from a clinical-grade IoT and making it interoperable with blockchain and other areas of the medical device ecosystem while empowering the patient to manage, own and access the information derived from the devices.
| Time | Session Name |
|---|---|
| 8:15 – 9:00 | Registration and Breakfast |
| 9:00 – 9:30 | Welcome: Why We Are Here The Roadmap to Adoption for Validated and Effective us of IoTs and Blockchain in Clinical Trials and Research Speaker: Maria Palombini, IEEE-SA |
| 9:30 – 10:10 | Meeting Demands in Hardware and Software for Clinical IoTs to Achieve Interoperability and Stakeholder Satisfaction Florence DiStefano Hudson Special Advisor, Trusted CI, The NSF Cybersecurity Center of Excellence at Indiana University; Lead, IEEE-SA Clinical IoT Data Validation and Interoperability with Blockchain Workstream |
| 10:10 – 10:50 | Clinical IoTs, Blockchain and the Connected Medical Device System Susan Ramonat, CEO, Spiritus Partners |
| 10:50 – 11:10 | TECH BREAK |
| 11:10 – 11:50 | Fixing the Patient Trust Deficit in IoMTs and Healthcare with Blockchain Nicholas Schmidt CTO, Embleema |
| 11:50 – 12:30 | Layering Intelligence to Clinical Wearable/IoT Data through the Responsible Application of AI Siddhi Trivedi Global Strategy Advisor, Lucidium |
| 12:30 – 13:15 | INTERACTIVE NETWORKING LUNCH |
| 13:15 – 13:55 | Interoperability and Security of Healthcare, Challenges of Current Approaches and Future Solutions Gilbert Verdian CEO and Founder, Quant |
| 14:00 – 16:15 | PART 1: Development of Building Blocks of Roadmap through Adoption All participants will contribute, vote and agree on top tier categories for building the roadmap to blockchain adoption. (Guidelines will be provided). Facilitators: IEEE-SA Team (Maria Palombini, Lloyd Green, Chirag Desai) |
| 16:15 – 16:30 | Closing Remarks: Outcomes of the Part 1 Roadmap Build. Plan for Day 2 Maria Palombini, IEEE-SA |
| 16:30 – 17:00 | Tour of the Clinical Innovation Zone (open to anyone who wants to participate) |
| 17:00 – 18:00 | Ice Breaker Reception for Blockchain for Clinical Trials Participants |
DAY 2: Blockchain for Clinical Trials Agenda
The agenda is currently in development. Session times and titles are subject to change as speakers are added to the program.
| Time | Session Name |
|---|---|
| 8:15 – 8:45 | Attendee Breakfast |
| 8:45 – 9:05 | Recap of Day 1 Roadmap Design. Start of Day 2 Maria Palombini, IEEE-SA |
| 9:05 – 9:50 | Pilot Study Update: Advocating to Help Cystic Fibrosis Patients Across the Globe with Blockchain Speakers: • Jeanne Barnette, Founder, CFTechnology.org • Robert Chu, CEO & Founder, Embleema |
| 9:50 – 10:30 | Blockchain for the Clinical Trial Supply Chain – Pfizer’s Latest Global Endeavor for Innovation and Patient Safety Speaker: Munther Baara, Head of New Clinical Paradigm, Pfizer |
| 10:30 – 10:50 | TECH BREAK |
| 10:50 – 11:50 | Interactive Consortia Panel: Lessons in Progress from POCs and Pilots for Public Patient Blockchain and Clinical Trials Consortia and working group leaders from IMI Blockchain Enabled Healthcare, PHUSE Blockchain Working Group, OpenPharma Initiative and others will provide insights in progress on developing alliances and establishing multi-organizational governance to enable a patient-centered blockchain for clinical trial efficacy and patient safety. Moderator: Florence Hudson, Special Advisor, Trusted CI, The NSF Cybersecurity Center of Excellence at Indiana University Panelists: • Scott Askin, Digital Solutions Director, Digital Development, Portfolio, Strategy & Innovation (PS&I), Novartis Pharma AG • Disa Lee Choun Director Head of GCSO Innovation, UCB; Co-Lead, phUSE Blockchain Health Working Group • Adama Ibrahim, EMBA, Associate Director, Clinical Operations | WIN UK Chapter Co-Lead Clinical Study Leadership, Biogen UK • Jim Nasr, Vice President, Technology & Innovation, Synchrogenix |
| 11:50 – 12:30 | Blockchain and Third-Party Risk Management (TPRM) Speaker: • Marco Cuomo, Global Lead, EWS Service Operations & Engineering, Novartis |
| 12:30 – 13:15 | INTERACTIVE LUNCH |
| 13:15 – 14:15 | Interactive Panel: The Maturation of Blockchain within the Pharmaceutical Framework Moderator: Siddhi Trivedi, Global Strategy Advisor, Lucidium • Jean-Remy Behaeghel, Sr Director, Clinical, Quality and Manufacturing Systems, Vertex Pharmaceuticals • Marco Cuomo, Global Lead, EWS Service Operations & Engineering, Novartis • Munther Baara, New Clinical Paradigm, Pfizer |
| 14:15 – 16:15 | Roadmap to Blockchain Adoption – PART II Working Group and Ideation Based on Agreed Roadmap Areas Afternoon Break Coffee, Tea and Treats Served |
| Working Group 1: Topic and Lead Announced Tuesday Morning Working Group 2: Topic and Lead Announced Tuesday Morning Working Group 3: Topic and Lead Announced Tuesday Morning |
|
| 16:15 – 16:45 | Report Out from the Working Groups |
| 16:45 – 17:00 | Closing Remarks – Maria Palombini, IEEE-SA |
| 17:00 – 18:00 | Networking Reception |
DAY 3: Blockchain for Clinical Trials Agenda
The agenda is currently in development. Session times and titles are subject to change as speakers are added to the program.
| Time | Session Name |
|---|---|
| 8:15 – 8:45 | Breakfast |
| 8:45 – 9:00 | Opening Remarks: Recap and next steps for Roadmap Design Plan for Day 2 Speaker: Maria Palombini, IEEE-SA |
| 9:00 – 9:30 | Distinguished Presentation Restoring Patient Trust in Clinical Trials through Digital Empowerment, Integrity and Identity Estelle Jobson Patient Advocate; Communications Manager at the Swiss Clinical Trial Organisation (SCTO) |
| 9:30 – 10:30 | Setting a New Standard for Electronic Informed Consent with Smart Contracts– What are we solving? Panelists: Dr. Mehdi Benchoufi, Chef de Clinique Assistant, Département d'Epidémiologie Clinique, Hôpital Hôtel Dieu Adama Ibrahim, EMBA,Associate Director, Clinical Operations | WIN UK Chapter Co-Lead Clinical Study Leadership, Biogen UK Darpan Ahuja Co-Founder, Consilx Moderator: Scott Askin, Novartis Digital Solutions Director Digital Development, Portfolio, Strategy & Innovation (PS&I) Novartis Pharma AG |
| 10:30 – 10:50 | TECH BREAK |
| TECHNOLOGY IN ACTION SESSIONS | |
| 10:50 – 11:20 | POC – Review Decentralised Physician Identity: The New Relationship between patients, clinicians and organisations and what it means for clinical trials. An overview and live demonstration of a working decentralised physician identity. We will discuss the benefits for clinical trials as well as the challenges of adoption and trust. The session will also cover the open standards of the underlying technologies. Speaker: Manreet Nijjar Co-Founder & CEO, Truu |
| 11:20 – 11:50 | Pilot Case Study- Veratrak partnership with Tjoapack All in One Package: Security, Compliance and Immutability to Secure the Pharmaceutical Supply Chain Veratrak has partnered with Tjoapack, a pharmaceutical packaging company, on a number of projects that focus on using the properties of blockchain to enable transparent collaboration across multiple pharmaceutical supply chain partners to drive information sharing through a secure digital chain. The Veratrak platform has been built according to GAMP5 guidelines and is compliant with FDA part 11 regulations, making it the first global application of blockchain in a GxP environment working with multiple organisations in the supply chain. Speaker: Jason Lacombe, CEO, Veratrak |
| 11:50 – 12:20 | POC Review The Need for Interoperability in Blockchain-Based Initiatives to Facilitate Clinical Trials: A Combined IHE/HL7 Approach Massimiliano Masi (M.Sc, Ph.D.) IT Security Architect, Tiani “Spirit” GmbH |
| 12:20 – 13:20 | Tech Panel Debate: What is right blockchain platform for my project? Moderator: Maria Palombini, IEEE-SA Panelists: • Robert Clint, CTO, Spiritus Partners • Darpan Ahuja, Co-Founder, Consilx • Manreet Manreet Nijjar, Co-Founder & CEO, Truu • Jason Lacombe, CEO, Veratrak |
| 13:20 – 13:30 | Closing Remarks: Speaker: Maria Palombini, IEEE-SA The next steps for publishing and adhering to the roadmap |
| 13:30 | Forum Adjourns with Networking Lunch |